T1	Participants 71 121	for moderate to severe facial erythema of rosacea:
T2	Participants 194 224	BACKGROUND Erythema of rosacea
T3	Participants 579 691	In study A, 122 subjects were randomized to receive a single application of BT 0·07%, 0·18%, 0·5% or vehicle.
T4	Participants 692 756	In study B (4-week treatment and 4-week follow-up), 269 subjects
T5	Participants 1833 1873	treatment of moderate to severe erythema
